B. Gabriele et al. / Tetrahedron Letters 51 (2010) 1663–1665
1665
(d) Patil, N. T.; Yamamoto, Y. Chem. Rev. 2008, 108, 3395–3442; (e) Cadierno, V.;
Crochet, P. Curr. Org. Synth. 2008, 5, 343–364; (f) Kirsch, S. F. Synthesis 2008,
3183–3204; (g) Shen, H. C. Tetrahedron 2008, 64, 3885–3903; (h) Shestopalov,
A. M.; Shestopalov, A. A.; Rodonovskaya, L. A. Synthesis 2008, 1–25; (i) Hashmi,
A. S. K. Chem. Rev. 2007, 107, 3180–3211; (j) Balme, G.; Bouyssi, D.; Monteiro, N.
Heterocycles 2007, 73, 87–124; (k) Kirsch, S. F. Org. Biomol. Chem. 2006, 4, 2076–
2080; (l) Moreau, C.; Belgacem, M. N.; Gandini, A. Top. Catal. 2004, 27, 11–30;
(m) Cacchi, S.; Fabrizi, G.; Goggiomani, A. Heterocycles 2002, 56, 613–632.
4. For very recent examples, see: (a) Egi, M.; Azechi, K.; Akai, S. Org. Lett. 2009, 11,
5002–5005; (b) Yoshida, M.; Al-Amin, M.; Shishido, K. Synthesis 2009, 2454–
2466; (c) Briel, D.; Askar, G. B.; Ortwein, J.; Unverferth, K. Pharmazie 2009, 64,
477–478; (d) Hu, L. X.; Boykin, D. W. Synthesis 2009, 2143–2145; (e) Saquib,
M.; Husain, I.; Kumar, B.; Shaw, A. K. Chem. Eur. J. 2009, 15, 6041–6049; (f)
Chen, C. W.; Luh, T. Y. Tetrahedron Lett. 2009, 50, 3263–3265; (g) Wang, A.;
Jiang, H.; Xu, Q. Synlett 2009, 929–932; (h) Sydnes, L. K.; Holmelid, B.; Sengee,
M.; Hanstein, M. J. Org. Chem. 2009, 74, 3430–3443; (i) Cao, H.; Jiang, H.; Yao,
W.; Liu, X. Org. Lett. 2009, 11, 1931–1933; (j) Ghasemnejad-Bosra, H.; Faraje,
M.; Habibzadeh, S. Helv. Chim. Acta 2009, 92, 575–578; (k) Xiao, X. J.; Zhang, J. L.
Adv. Synth. Catal. 2009, 351, 617–629; (l) Zhang, M.; Jiang, H.-F.; Neumann, H.;
Beller, M.; Dixneuf, P. H. Angew. Chem., Int. Ed. 2009, 48, 1681–1684; (m) Du, X.;
Song, F.; Lu, Y.; Chen, H.; Liu, Y. Tetrahedron 2009, 65, 1839–1845; (n) Li, P.;
Chai, Z.; Zhao, G.; Zhu, S.-Z. Tetrahedron 2009, 65, 1673–1678.
or Et, 28 mL). The autoclave was sealed and, while the mixture was stirred, the
autoclave was pressurized with CO (32 atm) and air (up to 40 atm). After being
stirred at 100 °C for 2 h, the autoclave was cooled, degassed, and opened. The
solvent was evaporated, and the products were purified by column
chromatography on silica gel (eluent: 9:1 hexane–acetone for 2a and 2b;
95:5 hexane–AcOEt for 2c and 2d; 6:4 hexane–acetone for 2e; 98:2 hexane–
AcOEt for 2a0) to give pure furans 2, which were fully characterized by
spectroscopic techniques and elemental analysis.11
11. Characterization data for products: For 2a: Yellow oil. IR (film):
m = 1739, 1442,
1256, 763 cmꢁ1 1H NMR (300 MHz, CDCl3): d = 7.04 (s, br, 1H), 3.82 (s, 3H),
;
2.98–2.90 (m, 2H), 2.13 (s, br, 3H), 1.69–1.57 (m, 2H), 1.42–1.28 (m, 2H), 0.92
(t, J = 7.3, 3H) ppm; 13C NMR (75 MHz, CDCl3): d = 165.2, 164.3, 137.9, 121.2,
113.2, 50.8, 30.2, 27.9, 22.4, 13.7, 9.9 ppm; GC–MS (EI, 70 eV): m/z = 196 (M+,
25), 154 (32), 153 (100), 139 (32), 135 (44), 123 (47); Anal. Calcd for C11H16O3
(196.24): C, 67.32; H, 8.22. Found: C, 67.23; H, 8.24. For 2b: Yellow oil. IR
(film):
m ;
= 1728, 1448, 1225, 758 cmꢁ1 1H NMR (300 MHz, CDCl3): d = 7.79–
7.74 (m, 1 H), 7.45–7.36 (m, 4 H), 7.24 (q, J = 0.9, 1H), 3.80 (s, 3H), 2.20 (d,
J = 0.9, 3H) ppm; 13C NMR (75 MHz, CDCl3): d = 164.9, 158.0, 139.2, 129.4,
129.1, 128.4, 128.1, 128.0, 122.6, 51.2, 10.0 ppm; GC–MS (EI, 70 eV): m/z = 216
(M+, 82), 185 (100), 128 (53), 127 (33); Anal. Calcd for C13H12O3 (216.23): C,
72.21; H, 5.59. Found: C, 72.30; H, 5.60. For 2c: Colorless oil. IR (film):
m = 1718,
1438, 1391, 1292, 1121, 758 cmꢁ1 1H NMR (300 MHz, CDCl3): d = 7.38–7.29
;
5. Several synthetic approaches to furan-3-carboxylic esters have been
developed; none of these methods, however, involve the direct carbonylation
of acyclic precursors. For recent leading examples, see: (a) Goodman, K. B.;
Bury, M. J.; Cheung, M.; Cichy-Knight, M. A.; Dowdell, S. E.; Dunn, A. K.; Lee, D.;
Lieby, J. A.; Moore, M. L.; Scherzer, D. A.; Sha, D.; Suarez, D. P.; Murphy, D. J.;
Harpel, M. R.; Manas, E. S.; McNulty, D. E.; Annan, R. S.; Matico, R. E.; Schwartz,
B. K.; Trill, J. J.; Sweitzer, T. D.; Wang, D.-y.; Keller, P. M.; Krawiec, J. A.; Jaye, M.
C. Bioorg. Med. Chem. Lett. 2009, 19, 27–30; (b) Barluenga, J.; Riesgo, L.; Vicente,
R.; López, L. A.; Tomás, M. J. Am. Chem. Soc. 2008, 130, 13528–13529; (c)
Tarwade, V.; Dmitrenko, O.; Bach, R. D.; Fox, J. M. J. Org. Chem. 2008, 73, 8189–
8197; (d) Blayo, A.-L.; Gree, D.; Gree, R.; Le Meur, S. Adv. Synth. Catal. 2008, 350,
417–476; (e) Alizadeh, A.; Oskueyan, Q.; Rostamnia, S.; Ghanbari-Niaki, A.;
Mohebbi, A. R. Synthesis 2008, 2929–2932; (f) Terzidis, M. A.; Tsoleridis, C. A.;
Stephanidou-Stephanatou, J.; Terzis, A.; Raptopoulou, C. P.; Psycharis, V.
Tetrahedron 2008, 64, 11611–11617; (g) Taguchi, Y.; Oishi, A.; Iida, H. Chem.
Lett. 2008, 37, 50–51; (h) Yoneda, Y.; Krainz, K.; Liebner, F.; Potthast, A.;
Rosenau, T.; Karakawa, M.; Nakatsubo, F. Eur. J. Org. Chem. 2008, 475–484; (i)
Ranu, B. C.; Laksmikanta, A.; Banerjee, S. Tetrahedron Lett. 2008, 49, 4613–4617.
6. For a recent review on the importance of the development of new atom-
economical processes, see: Trost, B. M. Acc. Chem. Res. 2002, 35, 695–705.
7. Several molecules incorporating the furan-3-carboxylic ester core have shown
(m, 5H), 7.27 (s, 1H), 3.70 (s, 3H), 3.04–2.96 (m, 2H), 1.76–1.64 (m, 2H), 1.47–
1.33 (m, 2H), 0.95 (t, J = 7.3, 3H) ppm; 13C NMR (75 MHz, CDCl3): d = 164.6,
164.2, 138.4, 132.2, 129.2, 127.9, 127.3, 112.3, 51.0, 30.2, 27.9, 22.4, 13.8 ppm;
GC–MS (EI, 70 eV): m/z = 258 (M+, 41), 215 (39), 197 (100), 183 (54), 128 (34),
127 (49); Anal. Calcd for C16H18O3 (258.31): C, 74.39; H, 7.02. Found: C, 74.19;
H, 7.03. For 2d: Yellow solid, mp = 27–28 °C. IR (KBr):
m
= 1717, 1540, 1482,
1385, 1266, 1152, 924, 768 cmꢁ1
;
1H NMR (300 MHz, CDCl3): d = 7.83–7.77 (m,
2H), 7.50 (s, 1H), 7.47–7.30 (m, 8H), 3.68 (s, 3H) ppm; 13C NMR (75 MHz,
CDCl3): d = 165.1, 156.6, 139.2, 131.7, 130.1, 129.2, 128.6, 128.33, 128.26,
127.7, 127.6, 113.7, 51.6 ppm; GC–MS (EI, 70 eV): m/z = 278 (M+, 100), 247
(92), 191 (42), 189 (55), 105 (42); Anal. Calcd for C18H14O3 (278.30): C, 77.68;
H, 5.07. Found: C, 77.60; H, 5.07. For 2e: Colorless oil. IR (film):
m = 1720, 1605,
1442, 1307, 1201, 1039, 736 cmꢁ1 1H NMR (300 MHz, CDCl3): d = 7.24 (d,
;
J = 2.0, 1H), 6.63 (d, J = 2.0, 1H), 3.82 (s, 3H), 3.00 (t, J = 7.7, 2H), 1.72–1.59 (m, 2
H), 1.42–1.29 (m, 2H), 0.93 (t, J = 7.3, 3H) ppm; 13C NMR (75 MHz, CDCl3):
d = 164.5, 163.5, 140.4, 113.0, 110.7, 51.2, 30.1, 27.3, 22.3, 13.7 ppm; GC–MS
(EI, 70 eV): m/z = 182 (M+, 56), 153 (42), 140 (96), 139 (87), 125 (47), 121 (74),
109 (100); Anal. Calcd for C10H14O3 (182.22): C, 65.91; H, 7.74. Found: C, 65.79;
H, 7.72. For 2a0: Colorless oil. IR (film):
m ;
= 1722, 1267, 1073 cmꢁ1 1H NMR
(300 MHz, CDCl3): d = 7.04 (q, J = 1.3, 1H), 4.29 (q, J = 7.2, 2H), 2.98–2.91 (m,
2H), 2.14 (d, J = 1.3, 3H), 1.69–1.58 (m, 2H), 1.42–1.26 (m, 2H), 1.35 (t, J = 7.2,
3H), 0.92 (t, J = 7.5, 3H) ppm; 13C NMR (75 MHz, CDCl3): d = 164.8, 164.1, 137.8,
121.2, 113.2, 59.8, 30.3, 28.0, 22.4, 14.4, 13.8, 10.0 ppm; GC–MS (EI, 70 eV):
m/z = 210 (M+, 29), 139 (100); Anal. Calcd for C12H18O3 (210.27): C, 68.54; H,
8.63. Found: C, 68.53; H, 8.64.
interesting
pharmacological
activities,
including
antihypertensive,
antimicrobial, and anticancer activity. For recent leading examples, see: (a)
Wang, J.; Zhang, H.; Yang, X.; Zhou, Y.; Wang, H.; Bai, H. J. Antibiot. 2008, 61,
623–626; (b) Moreno-Vargas, A. J.; Molina, L.; Carmona, A. T.; Ferrali, A.;
Robina, I.; Lambelet, M.; Spertini, O. Eur. J. Org. Chem. 2008, 2973–2982; (c)
Seham, S. Y. J. Heterocycl. Chem. 2007, 44, 21–27; (d) Woods, C. R.; Hack, M. D.;
Allison, B. D.; Phuong, V. K.; Rosen, M. D.; Morton, M. F.; Prendergast, C. E.;
Barrett, T. D.; Shankley, N. P.; Rabinowitz, M. H. Bioorg. Med. Chem. Lett. 2007,
17, 6905–6909; (e) Dominguez, C.; Smith, L.; Huang, Q.; Yuan, C.; Ouyang, X.;
Cai, L.; Chen, P.; Kim, J.; Harvey, T.; Syed, R.; Kim, T.-S.; Tasker, A.; Wang, L.;
Zhang, M.; Coxon, A.; Bready, J.; Starnes, C.; Chen, D.; Gan, Y.; Neervannan, S.;
Kumar, G.; Polverino, A.; Kendall, R. Bioorg. Med. Chem. Lett. 2007, 17, 6003–
6008; (f) de Oliveira, R. B.; de Souza-Fagundes, E. M.; Siqueira, H. A. J.; Leite, R.
S.; Donnici, C. L.; Zani, C. L. Eur. J. Med. Chem. 2006, 41, 756–760; (g) Funk, O. F.;
Kettmann, V.; Drimal, J.; Langer, T. J. Med. Chem. 2004, 47, 2750–2760.
12. For reviews on PdI2-catalyzed oxidative carbonylation reactions, see: (a)
Gabriele, B.; Salerno, G. Cyclocarbonylation. In Handbook of Organopalladium
Chemistry for Organic Synthesis; Negishi, E., Ed.; Wiley-Interscience: New York,
2002; Vol. II, pp 2623–2641; (b) Gabriele, B.; Salerno, G.; Costa, M.; Chiusoli, G.
P. J. Organomet. Chem. 2003, 687, 219–228; (c) Gabriele, B.; Salerno, G.; Costa,
M.; Chiusoli, G. P. Curr. Org. Chem. 2004, 8, 919–946; (d) Gabriele, B.; Salerno,
G.; Costa, M. Synlett 2004, 2468–2483; (e) Gabriele, B.; Salerno, G. PdI2. In E-
EROS (Electronic Encyclopedia of Reagents for Organic Synthesis); Crich, D., Ed.;
John Wiley & Sons: Chichester, 2006; (f) Gabriele, B.; Salerno, G.; Costa, M. Top.
Organomet. Chem. 2006, 18, 239–272.
13. For recent examples on PdI2-catalyzed oxidative carbonylation reactions, see:
(a) Gabriele, B.; Mancuso, R.; Salerno, G.; Ruffolo, G.; Costa, M.; Dibenedetto, A.
Tetrahedron Lett. 2009, 50, 7330–7332; (b) Della Cà, N.; Campanini, F.; Gabriele,
B.; Salerno, G.; Massera, C.; Costa, M. Adv. Synth. Catal. 2009, 351, 2423–2432;
(c) Gabriele, B.; Mancuso, R.; Salerno, G.; Lupinacci, E.; Ruffolo, G.; Costa, M. J.
Org. Chem. 2008, 73, 4971–4977; (d) Gabriele, B.; Plastina, P.; Salerno, G.;
Mancuso, R.; Costa, M. Org. Lett. 2007, 9, 3319–3322; (e) Plastina, P.; Gabriele,
B.; Salerno, G. Synthesis 2007, 3083–3087; (f) Gabriele, B.; Plastina, P.; Salerno,
G.; Mancuso, R. Synthesis 2006, 4247–4251; (g) Gabriele, B.; Salerno, G.; Fazio,
A.; Veltri, L. Adv. Synth. Catal. 2006, 348, 2212–2222; (h) Gabriele, B.; Salerno,
G.; Veltri, L.; Mancuso, R.; Li, Z.; Crispini, A.; Bellusci, A. J. Org. Chem. 2006, 71,
7895–7898; (i) Bacchi, A.; Costa, M.; Della Cà, N.; Gabriele, B.; Salerno, G.;
Cassoni, S. J. Org. Chem. 2005, 70, 4971–4979; (j) Gabriele, B.; Plastina, P.;
Salerno, G.; Costa, M. Synlett 2005, 935–938.
8. Substrates
-hydroxy aldehyde or
R3C„CMgBr.
1
were easily prepared by alkynylation of the appropriate
a
a
-hydroxy ketone using an excess of R3C„CLi or
9. These conditions (32 atm of CO together with 9 total atm of air, considering
that the autoclave was loaded under 1 atm of air) corresponded to 78.0% of CO
in air and were outside the explosion limits for CO in air (ca. 16–70% at 18–20
°C and atmospheric pressure, 14.8–71.4% at 100 °C and atmospheric pressure.
At higher total pressure, the range of flammability decreases: for example, at
20 atm and 20 °C the limits are ca. 19% and 60%. See: Bartish, C. M.; Drissel, G.
M. In: Kirk-Othmer Encyclopedia of Chemical Technology; Grayson, M., Eckroth,
D., Bushey, G. J., L. Campbell, L., Klingsberg, A., van Nes, L., Eds., 3rd ed.; Wiley-
Interscience: New York, 1978; Vol. 4, p 775.
10. Typical procedure for the oxidative carbonylative annulation of 3-yne-1,2-diols
1
to furan-3-carboxylic esters 2:
A
250 mL stainless steel autoclave was
14. Gabriele, B.; Costa, M.; Salerno, G.; Chiusoli, G. P. J. Chem. Soc., Perkin Trans. 1
1994, 84–87.
charged in the presence of air with PdI2 (5.0 mg, 1.39 ꢀ 10ꢁ2 mmol), KI
(11.5 mg, 6.93 ꢀ 10ꢁ2 mmol), and a solution of 1 (1.39 mmol) in ROH (R = Me